Science

Overview

HypGen Inc is focused on the treatment of Central Nervous System diseases. We are developing protocols for two indications in phase I/II for both Parkinson’s disease and Stroke. HypGen is focused on treating the disease rather than the symptoms for a better likelihood of success.